July 19, 2024

Pet Diabetes Care Devices Market Size, Share, Report by 2033

The global pet diabetes care devices market size was estimated at USD 2.48 billion in 2023 and is anticipated to grow around USD 4.91 billion by 2033, growing at a CAGR of 7.05% from 2024 to 2033.

Key Points

  • North America held the largest market share of 37% in 2023.
  • The Asia-Pacific region is observed to witness the fastest rate of expansion during the forecast period.
  • By device, the insulin delivery devices segment has contributed more than 93% of the market share in 2023.
  • By animal, the dogs segment led the market with the major market share of 55% in 2023.
  • By end-users, the veterinary hospitals segment has recorded more than 42% of the market share in 2023.

Pet Diabetes Care Devices Market Size 2024 to 2033

The Pet Diabetes Care Devices Market is witnessing substantial growth driven by the rising prevalence of diabetes among pets, increasing awareness about pet health, and advancements in veterinary diagnostics and treatment options. Diabetes mellitus, a chronic metabolic disorder characterized by high blood sugar levels, affects a significant number of pets, including dogs and cats. As pet owners become more conscious of their pets’ health and well-being, there is a growing demand for effective diabetes management solutions. This has led to the development of innovative pet diabetes care devices designed to monitor blood glucose levels, administer insulin, and facilitate better disease management in pets.

Get a Sample: https://www.precedenceresearch.com/sample/3970

Growth Factors:

Several factors contribute to the growth of the Pet Diabetes Care Devices Market. Firstly, the increasing incidence of diabetes among pets, particularly dogs and cats, is a primary driver. Factors such as genetic predisposition, obesity, lack of exercise, and dietary habits contribute to the development of diabetes in pets, leading to a growing need for diabetes management solutions.

Furthermore, the rising awareness about pet health and the growing human-animal bond are driving pet owners to seek advanced healthcare solutions for their pets, including diabetes management. Pet owners are increasingly willing to invest in advanced veterinary care, including monitoring devices, insulin delivery systems, and specialized diets, to ensure the well-being of their diabetic pets.

Moreover, advancements in veterinary diagnostics and treatment options have expanded the scope of diabetes management in pets. Technological innovations in blood glucose monitoring devices, such as continuous glucose monitors (CGMs) and glucometers, enable pet owners and veterinarians to accurately monitor blood sugar levels in diabetic pets, facilitating timely adjustments to insulin therapy and dietary management.

Additionally, the growing availability of pet insurance and the rising affordability of veterinary care have made advanced diabetes management options more accessible to pet owners. Insurance coverage for diabetic pet care, including medications, monitoring devices, and veterinary consultations, encourages pet owners to seek timely diagnosis and treatment for their diabetic pets, driving market growth.

Furthermore, collaborative efforts between veterinary professionals, pet care companies, and academic institutions have led to the development of innovative pet diabetes care devices. Research initiatives focused on understanding the pathophysiology of diabetes in pets, exploring novel treatment modalities, and improving diagnostic tools contribute to the development of advanced diabetes management solutions for pets.

Region Insights:

The Pet Diabetes Care Devices Market exhibits regional variations in terms of prevalence rates, pet ownership trends, veterinary healthcare infrastructure, and regulatory frameworks. In North America, the United States and Canada dominate the market, driven by a large pet population, high pet ownership rates, and advanced veterinary care infrastructure. The presence of leading pet care companies, research institutions, and veterinary clinics in the region further contributes to market growth.

In Europe, countries such as the United Kingdom, Germany, France, and Italy represent key markets for pet diabetes care devices. The region benefits from a well-established pet care industry, increasing pet humanization trends, and growing awareness about pet health and wellness. Regulatory initiatives aimed at ensuring the safety and efficacy of pet diabetes care devices also contribute to market growth in Europe.

In the Asia Pacific region, countries like Japan, China, and Australia are witnessing significant growth in the Pet Diabetes Care Devices Market. Rising pet ownership rates, urbanization trends, and increasing disposable incomes drive demand for advanced pet healthcare solutions, including diabetes management devices. Moreover, expanding veterinary care infrastructure and a growing focus on preventive pet healthcare support market growth in the region.

Latin America and the Middle East & Africa regions also present growth opportunities for the Pet Diabetes Care Devices Market, driven by increasing pet adoption rates, rising awareness about pet health, and improving access to veterinary care services. However, challenges such as limited awareness about diabetes in pets, socio-economic factors, and regulatory constraints may hinder market growth in these regions.

Pet Diabetes Care Devices Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 7.05%
Global Market Size in 2023 USD 2.48 Billion
Global Market Size by 2033 USD 4.91 Billion
U.S. Market Size in 2023 USD 640 Million
U.S. Market Size by 2033 USD 1,270 Million
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Device, By Animal, and By End-use
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Pet Diabetes Care Devices Market Dynamics

Drivers:

Several drivers are driving the growth of the Pet Diabetes Care Devices Market. Firstly, the increasing prevalence of diabetes among pets, particularly dogs and cats, is a major driver. Factors such as genetic predisposition, obesity, lack of exercise, and dietary habits contribute to the rising incidence of diabetes in pets, creating a growing need for effective diabetes management solutions.

Furthermore, the growing awareness about pet health and the human-animal bond is driving pet owners to seek advanced healthcare solutions for their pets, including diabetes management devices. Pet owners are increasingly willing to invest in monitoring devices, insulin delivery systems, and specialized diets to ensure the well-being of their diabetic pets, driving market growth.

Moreover, advancements in veterinary diagnostics and treatment options have expanded the scope of diabetes management in pets. Technological innovations in blood glucose monitoring devices, such as continuous glucose monitors (CGMs) and glucometers, enable pet owners and veterinarians to accurately monitor blood sugar levels in diabetic pets, facilitating timely adjustments to insulin therapy and dietary management.

Additionally, the availability of pet insurance and the affordability of veterinary care have made advanced diabetes management options more accessible to pet owners. Insurance coverage for diabetic pet care, including medications, monitoring devices, and veterinary consultations, encourages pet owners to seek timely diagnosis and treatment for their diabetic pets, driving market growth.

Furthermore, collaborative efforts between veterinary professionals, pet care companies, and academic institutions have led to the development of innovative pet diabetes care devices. Research initiatives focused on understanding the pathophysiology of diabetes in pets, exploring novel treatment modalities, and improving diagnostic tools contribute to the development of advanced diabetes management solutions for pets.

Opportunities:

The Pet Diabetes Care Devices Market presents several opportunities for stakeholders across the value chain. Firstly, there is a growing demand for advanced blood glucose monitoring devices and insulin delivery systems for pets, creating opportunities for companies to develop innovative products tailored to the specific needs of diabetic pets.

Moreover, there is an increasing focus on preventive pet healthcare and wellness, driving demand for integrated diabetes management solutions that encompass dietary management, exercise regimens, and regular monitoring of blood glucose levels. Companies can capitalize on this trend by offering comprehensive diabetes management programs and personalized healthcare solutions for diabetic pets.

Furthermore, advancements in technology, such as wearable devices, mobile applications, and telemedicine platforms, present opportunities for remote monitoring and management of diabetic pets. These digital health solutions enable pet owners and veterinarians to monitor blood glucose levels, track medication adherence, and communicate effectively, enhancing the quality of diabetes care for pets.

Additionally, there is a growing emphasis on personalized medicine and precision healthcare in the veterinary sector, opening avenues for the development of tailored treatment regimens and therapeutic interventions for diabetic pets. Companies can leverage advancements in genetics, biomarker research, and data analytics to develop personalized diabetes management strategies that optimize outcomes for diabetic pets.

Furthermore, expanding pet insurance coverage and reimbursement policies for diabetes care present opportunities for companies to partner with insurers and pet care providers to offer value-added services, such as disease management programs, adherence support, and educational resources for pet owners.

Moreover, there is untapped potential in emerging markets and underserved regions with limited access to veterinary care services. Companies can expand their presence in these markets by offering affordable, user-friendly diabetes care devices, leveraging digital health technologies, and partnering with local stakeholders to raise awareness about diabetes in pets and promote preventive healthcare practices.

Challenges:

Despite the growth prospects, the Pet Diabetes Care Devices Market faces several challenges that must be addressed to realize its full potential. Firstly, there is a lack of standardized diagnostic criteria and treatment guidelines for diabetes in pets, leading to variations in clinical practice and treatment outcomes. Harmonizing diagnostic protocols, establishing evidence-based treatment guidelines, and promoting interdisciplinary collaboration are essential to improve diabetes management in pets.

Read Also: Vibration Sensor Market Size to Rake USD 12.44 Bn by 2033

Recent Developments

  • In November 2023, Boehringer Ingelheim got approval for SENVELGO® in Europe. This is the first oral liquid medication available for diabetic cats, and it represents a significant advancement in treating feline diabetes in Europe. SENVELGO® can be given to cats once a day, either mixed with a small amount of food or directly administered into their mouth.
  • In May 2023, UBI introduced the Petrackr, a diabetes monitoring device for pets. The product consists of a device and single-use test strips for collecting a small drop of blood sample and a hand-held monitor that can supervise multiple profiles of pets. The device accurately tracks, monitors, and displays the blood glucose levels of pets. The product has distribution partnerships in the United States and Canada.
  • In Feb 2023, ALRT, a Singapore-based medical device company, launched GluCurve Pet CGM. It is a continuous monitoring device for diabetic cats and dogs produced in collaboration with Covetrus. It is designed to make diabetes management more effortless.

Pet Diabetes Care Devices Market Companies

  • Merck animal health
  • Becton
  • Fitbark
  • TaiDoc
  • Dickinson
  • Allison Medical
  • Henry Schein
  • Zoetis
  • Ulticare
  • Boehringer Ingelheim Vetmedica Inc.
  • IDEXX Laboratories
  • Johnson & Johnson Services, Inc
  • Novo Nordisk
  • Eli Lilly and Company
  • Vetoquinol S.A.

Segments Covered in the Report

By Device

  • Glucose Monitoring Devices
  • Insulin Delivery Devices
  • Insulin Delivery Pen
  • Insulin Delivery Syringes

By Animal

  • Dogs
  • Cats
  • Horses

By End-use

  • Veterinary Clinics
  • Home Care Settings
  • Veterinary Hospitals

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.autoindustrybulletin.com/

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *